Full Text View
Tabular View
No Study Results Posted
Related Studies
Vigabatrin Ph 2a Cocaine Interaction Study
This study is currently recruiting participants.
Study NCT00626834   Information provided by National Institute on Drug Abuse (NIDA)
First Received: February 18, 2008   Last Updated: June 17, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cocaine Addiction
Additional conditions recognized in this trial
Behavior, Addictive
Cocaine-Related Disorders
More general conditions related to this trial
Compulsive Behavior
Disorders of Environmental Origin
Impulsive Behavior
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Vigabatrin
Matching placebo
Additional drug interventions recognized in this trial
Central Nervous System Agents
Central Nervous System Stimulants
Cocaine
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Anticonvulsants
Cardiovascular Agents
Central Nervous System Depressants
Dopamine Agents
Dopamine Uptake Inhibitors
Enzyme Inhibitors
GABA Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services